Jessica Kay Jeffrey

Jessica Kay Jeffrey is an Associate Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA. Her work focuses on innovative approaches to mental health treatment, particularly in the areas of psychedelic therapy, adolescent psychiatry, and integrated care models.

Dr. Jeffrey's research spans several key areas of psychiatry with emphasis on adolescent mental health, psychedelic-assisted therapy, and collaborative treatment approaches. Her work on psilocybin for depression treatment represents cutting-edge research in novel therapeutic approaches. She has developed screening tools for behavioral health in pediatric primary care and explored technology applications to improve mental health service delivery. Her research program demonstrates a commitment to evidence-based, patient-centered care with focus on measurement-based approaches and interdisciplinary collaboration.

Her publication record shows a progression toward innovative mental health treatments, with recent work focusing on psychedelic therapeutics for adolescents and adults with depression. She has contributed significantly to discussions about ethical considerations, safety protocols, and clinical applications of these emerging treatments. Her research also emphasizes collaborative care models integrating psychiatrists, nurses, and pharmacists to optimize treatment outcomes.

Dr. Jeffrey maintains an active collaboration network with prominent UCLA researchers including Charles Grob, Marc Weintraub, Patricia Lester, Nastassia Hajal, and David Miklowitz. Her work has been cited extensively and discussed across various platforms, indicating significant impact in the field of mental health research and practice.